Yi Yang
Business Development Representative Biocytogen
Seminars
Wednesday 10th June 2026
RenSuperscript Biologics: Empowering Next-Generation ADCs with AI-Driven Precision and Scalability
2:45 pm
- Seamless CMC via RenLiteSuperscript: Leverages the RenLite® common light chain to eliminate mismatching, ensuring high homogeneity and "antibody-like" stability for complex Dual-payload formats
- Synergistic Strategy to Overcome Resistance: Combines two distinct, complementary mechanisms of action on a single molecule to tackle tumor heterogeneity and bypass the resistance common in single-payload ADCs
- AI-Driven Rapid Discovery: The RenSuper Workstation AI Platform scans 200+ TAA targets and hundreds of thousands of ready-to-go antibodies to match the ideal lead with optimal internalization in record time
